HCM
HUTCHMED DRC
NASDAQ: HCM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.36
-1.69% today
Updated 2026-04-29
Market cap
$2.30B
P/E ratio
5.04
P/S ratio
4.19x
EPS (TTM)
$2.65
Dividend yield
—
52W range
$13 – $20
Volume
0.0M
WallStSmart proprietary scores
42
out of 100
Grade: D
Sell
Investment rating
3.3
Growth
D6.5
Quality
B6.0
Profitability
B8.3
Valuation
A3/9
Piotroski F-Score
Weak
1.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$22.85
+71.03%
12-Month target
$13.80
+3.29%
Intrinsic (DCF)
$31.70
Margin of safety
+52.33%
1 Strong Buy9 Buy2 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 83.30% — above average
+ ROE 45.30% — strong efficiency
+ 52.33% below intrinsic value
+ Debt/equity 0.08x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 0.95 — distress zone
- Negative free cash flow $-79.01M
- Revenue declining -16.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $426.41M | $838.00M | $630.20M | $549.96M | $548.51M |
| Net income | $-360.83M | $100.78M | $37.73M | $458.12M | $458.12M |
| EPS | — | — | — | — | $2.65 |
| Free cash flow | $-305.26M | $186.65M | $-17.44M | $-79.01M | $-79.01M |
| Profit margin | -84.62% | 12.03% | 5.99% | 83.30% | 83.30% |
Peer comparison
Smart narrative
HUTCHMED DRC trades at $13.36. representing a P/E of 5.04x trailing earnings. Our Smart Value Score of 42/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.95, it sits in the distress. TTM revenue stands at $548.51M. with profit margins at 83.30%. Our DCF model estimates intrinsic value at $31.70.
Frequently asked questions
What is HUTCHMED DRC's stock price?
HUTCHMED DRC (HCM) trades at $13.36.
Is HUTCHMED DRC overvalued?
Smart Value Score 42/100 (Grade D, Sell). DCF value $31.70.
What is the price target of HUTCHMED DRC (HCM)?
The analyst target price is $22.85, representing +71.0% upside from the current price of $13.36.
What is the intrinsic value of HUTCHMED DRC (HCM)?
Based on our DCF model, intrinsic value is $31.70, a +52.3% margin of safety versus $13.36.
What is HUTCHMED DRC's revenue?
TTM revenue is $548.51M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
0.95 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.19x
ROE45.30%
Beta0.45
50D MA$14.52
200D MA$15.17
Shares out0.17B
Float0.51B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—